Biodegradable Polymer Microimplants for Sustained Drug Delivery

Solution Overview

Problem

Current methods for drug and live cell delivery, such as microneedle arrays, face limitations in material selection due to the need for sharp edges for tissue penetration, which restricts the use of softer materials like hydrogels, and lack effective solutions for sustained delivery of iron for anemia treatment and antifungal drugs for nail infections, as well as inefficiencies in delivering Botox and vaccines without causing side effects or waste.

Innovation Solution

Development of biodegradable or biostable polymer-based microimplants that can be formed in situ within the skin tissue, allowing for the creation of artificial cavities to house drug or cell compositions, eliminating the need for sharp edges and enabling sustained release, and using oscillating needles or microneedle arrays for precise delivery of iron and antifungal agents, and delivering Botox in a solid state to reduce waste and side effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If microneedle arrays are used for drug delivery, then sharp edges are needed for tissue penetration, but this restricts the use of softer materials like hydrogels

Engineering Contradiction:
Core Design Contradiction:
StrengthVSAdaptability or versatility

Solution Approach 1:

The microneedle array is divided into two functional parts: a biodegradable support structure that provides mechanical strength and sharp edges for penetration, and a separate drug-containing composition that can be made from softer materials like hydrogels. The support structure degrades after insertion, leaving the drug composition to deliver therapeutically.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses composite construction where a biodegradable polymer support (such as PLA or PGA) is combined with a drug-containing composition (such as hydrogel-based formulations). The support provides the necessary mechanical properties for sharp edges and tissue penetration, while the drug composition can utilize softer, more versatile materials that would otherwise be unsuitable for microneedle construction.

Inventive Principle:
Principle #40Composite materials

2Duration of action of moving object

If biodegradable polymers are used for microimplants, then sustained delivery is achieved, but manufacturing precision is reduced

Engineering Contradiction:
Core Design Contradiction:
Duration of action of moving objectVSManufacturing precision

Solution Approach 1:

The biodegradable polymer support structure is pre-formed with precise geometric features (such as microneedle shapes and cavity structures) before implantation. This preliminary manufacturing of the support structure allows for high precision in the delivery device, while the biodegradable nature enables sustained drug release over time as the support gradually degrades in the body.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If iron supplements are delivered for anemia treatment, then treatment efficacy is improved, but side effects increase

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The iron supplement delivery system extracts iron from its traditional oral supplement form and delivers it directly to the target tissue through microneedle arrays. This localized delivery bypasses the gastrointestinal tract, eliminating common side effects such as constipation and nausea while maintaining treatment efficacy for anemia.

Inventive Principle:
Principle #2Taking out (Extraction)

4Reliability

If antifungal drugs are delivered for nail infections, then treatment effectiveness is improved, but drug waste increases

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The antifungal drug composition is delivered locally directly to the infected nail tissue through microneedle arrays. This localized delivery concentrates the drug where it is needed most, improving treatment effectiveness while minimizing systemic exposure and reducing overall drug consumption, thereby reducing drug waste.

Inventive Principle:
Principle #3Local quality

5Ease of operation

If Botox is delivered in liquid form, then delivery is simple, but side effects and waste increase

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The Botox composition is delivered in a solid or semi-solid state within the microneedle array rather than as a liquid injection. This phase change allows for precise dosage control, reduced diffusion to surrounding tissues (minimizing side effects), and elimination of the need for complex reconstitution and injection procedures, maintaining ease of use while improving safety.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables efficient, minimally invasive, and sustained drug or cell delivery with reduced side effects and waste, improving treatment efficacy for conditions like anemia, nail infections, and surgical pain, while allowing for the use of softer materials and precise control over drug release.

Implementation Method 1

The microimplants may be made from biostable or biodegradable polymer

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

using oscillating needles or microneedle arrays for precise delivery

Methodology Applied
Scientific EffectMechanical vibration: Vibration

Data Source

PatentUS11969398B2Methods, compositions, and devices for making sustained biodegradable implants in tissue
Publication Date: 2024.04.30
  • US11969398B2 patent drawing
  • US11969398B2 patent drawing
  • US11969398B2 patent drawing

AI summary

This invention discloses methods and composition to form biodegradable polymer implant arrays in the live tissue. Artificial cavities are created in the live tissue by using laser ablation, oscillating needle, microneedle array and other methods. The cavities are then filled with biodegradable polymer solution. The solvent in the polymer solution is dissipated in the tissue to form a biodegradable polymer implant in artificial cavities. The cavities and implants formed are arranged to form of an array of implants. The biodegradable polymer in the cavity can also be loaded with drug to form biodegradable drug delivery array in the live tissue.